Page last updated: 2024-11-03

propofol and Digestive System Disorders

propofol has been researched along with Digestive System Disorders in 10 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Although obesity was associated with an increased frequency of SRCs, propofol sedation can be used safely in obese patients undergoing AEPs when administered by trained professionals."7.77Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. ( Azar, R; Cote, GA; Early, D; Edmundowicz, SA; Hall, M; Hovis, CE; Hovis, RM; Jonnalagadda, SS; Kushnir, V; Mullady, DK; Murad, F; Waldbaum, L; Wani, S, 2011)
"Although obesity was associated with an increased frequency of SRCs, propofol sedation can be used safely in obese patients undergoing AEPs when administered by trained professionals."3.77Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. ( Azar, R; Cote, GA; Early, D; Edmundowicz, SA; Hall, M; Hovis, CE; Hovis, RM; Jonnalagadda, SS; Kushnir, V; Mullady, DK; Murad, F; Waldbaum, L; Wani, S, 2011)
"Propofol was administered by bolus injection, with a standard protocol of 40 mg for patients <70 years old, 30 mg for patients 70-89 years old, and 20 mg for patients 90 years or older."2.74Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults. ( Hidaka, N; Horiuchi, A; Ichise, Y; Kajiyama, M; Nakayama, Y; Tanaka, N, 2009)
"Mean propofol dose was 301 mg (range 100-1000 mg)."1.32Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. ( Raymond, G; Sahai, AV; Yusoff, IF, 2004)
"Propofol is a rapidly acting agent that produces an excellent hypnotic state, but its use is typically limited to anesthesiologist-assisted cases because of the inadequacy of current monitoring standards to reliably detect early stages of respiratory depression."1.31Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series. ( Conwell, DL; Dumot, JA; Morrow, JB; Shay, SS; Vargo, JJ; Zuccaro, G, 2000)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohe, Y1
Kunimasa, K1
Watanabe, Y1
Wehrmann, T1
Riphaus, A1
Cohen, LB1
Horiuchi, A1
Nakayama, Y1
Hidaka, N1
Ichise, Y1
Kajiyama, M1
Tanaka, N1
Cho, JH1
Kim, JH1
Lee, YC1
Song, SY1
Lee, SK1
Lee, CK1
Lee, SH2
Chung, IK1
Lee, TH1
Park, SH1
Kim, EO1
Kim, HS1
Kim, SJ1
Wani, S1
Azar, R1
Hovis, CE1
Hovis, RM1
Cote, GA1
Hall, M1
Waldbaum, L1
Kushnir, V1
Early, D1
Mullady, DK1
Murad, F1
Edmundowicz, SA1
Jonnalagadda, SS1
Külling, D1
Rothenbühler, R1
Inauen, W1
Yusoff, IF1
Raymond, G1
Sahai, AV1
Vargo, JJ1
Zuccaro, G1
Dumot, JA1
Shay, SS1
Conwell, DL1
Morrow, JB1

Clinical Trials (7)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Value of Integrated Pulmonary Index Monitoring[NCT05356819]154 participants (Actual)Interventional2018-10-01Completed
Incidence of Sedation Related Complications With Propofol Alone Versus Propofol With Benzodiazepines and Opiates in a High Risk Group Undergoing Advanced Endoscopic Procedures: A Randomized Controlled Trial[NCT01315158]36 participants (Actual)Interventional2011-01-31Terminated (stopped due to - The research team is not able to obtain the necessary support to continue the study.)
Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?[NCT02635217]200 participants (Actual)Interventional2016-01-31Completed
[NCT01491126]170 participants (Anticipated)Observational2012-01-31Not yet recruiting
Phase 4, Prospective, Randomized, Double-blinded, Placebo-controlled Study Comparing Propofol vs. Midazolam Plus Propofol for Nonanesthesiologist Targeted Moderate Sedation in Outpatient Colonoscopy[NCT01428882]Phase 4135 participants (Actual)Interventional2011-06-30Completed
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures[NCT03529461]56 participants (Actual)Interventional2017-04-25Completed
Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy[NCT05437497]264 participants (Anticipated)Interventional2021-08-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants Who Experience Airway Maneuvers

In high risk patients (meeting at least of 1 of 3 criteria: ASA ≥ 3, BMI ≥ 30, those at risk for OSA) undergoing advanced endoscopy procedures, compare the number of participants who experience airway maneuvers (AMs) when sedated with propofol alone versus propofol in combination with benzodiazepines and opioids. (NCT01315158)
Timeframe: One day (during procedure)

Interventionparticipants (Number)
Propofol+Benzo/Opioids4
Propofol Alone4

Number of Participants Who Experience Other Sedation Related Complications

Compare the number of participants who experience other sedation related complications such as hypotension, hypoxemia and need for termination of the procedure between the two groups (NCT01315158)
Timeframe: One day (during procedure)

Interventionparticipants (Number)
Propofol+Benzo/Opioids0
Propofol Alone0

Number of Participants Who Experience Symptoms of Nausea and Vomiting Will be Compared Between the Two Groups

The number of participants who experience symptoms of nausea and vomiting in the two groups of patients will be recorded. This will be recorded during the follow-up phone call made 24-48 hours after the procedure. (NCT01315158)
Timeframe: 24-48 hours

Interventionparticipants (Number)
Propofol+Benzo/Opioids2
Propofol Alone1

Predictors of Sedation Related Complications as Measured by Early Procedure Termination for an Alternative Sedation Related Complication

(NCT01315158)
Timeframe: One year

Interventionincidences (Number)
Propofol+Benzo/Opioids0
Propofol Alone0

Predictors of Sedation Related Complications as Measured by Hypopnea/Apnea (Defined as Fewer Than 6 Breaths/Minute Based on Capnography)

(NCT01315158)
Timeframe: One year

Interventionincidences (Number)
Propofol+Benzo/Opioids0
Propofol Alone0

Predictors of Sedation Related Complications as Measured by the Incidences of Hypotension (Defined as Systolic Blood Pressure of Less Than 90mmHg or a Decrease of More Than 25% From Baseline)

(NCT01315158)
Timeframe: One year

Interventionincidences (Number)
Propofol+Benzo/Opioids0
Propofol Alone0

Predictors of Sedation Related Complications as Measured by the Number of Participants Who Experience Hypoxemia (Defined as a Pulse Oximetry <90% for Any Duration)

(NCT01315158)
Timeframe: One year

Interventionparticipants (Number)
Propofol+Benzo/Opioids0
Propofol Alone0

Duration of Recovery After the Endoscopic Procedure

"After completion of the procedure, the patient stood in the examination room monitored continuously by a nurse. When patients responded to normal verbal command, they were asked to sit up and were offered a drink. This was considered the early recovery time.~If they were able to stand unassisted by the bed and had stable hemodynamics parameters (saturation>90 % on room air and blood pressure and heart rate within 20 % of baseline), they were transferred to a locker room accompanied by a relative. The discharge criteria included ability to stand unassisted and tolerate clear liquids once dressed. Once a patient met discharge criteria, they were allowed to leave at their own discretion" (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy

,
Interventionminutes (Mean)
Early recovery timeDischarge time
Midazolam Balanced Propofol Sedation6.810.4
Single-agent Propofol Sedation5.39.80

Level of Sedation Throughout the Entire Procedure

Assessment every two minutes of the level of sedation during the endoscopic procedure, rating it as minimal, moderate or deep. (NCT01428882)
Timeframe: Up to 1 hour after introduction of the colonoscope

,
Interventionparticipants (Number)
Deep sedation at any pointDeep sedation at minute 4Deep sedation at minute 6Deep sedation at minute 8
Midazolam Balanced Propofol Sedation22101210
Single-agent Propofol Sedation9123

Rate of Patients and Physician Satisfaction With Sedation

"Endoscopists and patients rated their satisfaction with sedation in a 10-cm visual analogue scale after discharge.The patients were contacted 24-48 h after the procedure to answer a questionnaire regarding if they remembered scope insertion or scope removal and willingness to repeat it with a similar protocol and rated their satisfaction and pain perception from 0 to 10. This phone survey was done by the nurse specifically making the measurements in the endoscopy room, who was blinded to the sedation regimen.~For the interpretation of results of the 0-10 point numerical scale, 0 stands for 'extremely dissatisfied with sedation level during the endoscopic procedure', whereas 10 stands for 'extremely satisfied with sedation level during the endoscopic procedure." (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy for endoscopists and up to 48 hours for patients

,
Interventionunits on a scale (Mean)
Endoscopist SatisfactionPatient Satisfaction
Midazolam Balanced Propofol Sedation8.99.8
Single-agent Propofol Sedation8.49.5

Rate of Sedation-related Complications During the Procedure and the Recovery Phases

The following events were considered complications of procedural sedation: a decline in oxygen saturation to less than 85 % longer than 30 s after increasing the oxygen flow rate to 5 L/min and transient propofol interruption, a heart rate less than 40 beats per minute and blood pressure less than 80/50 mmHg. Major complications were defined as need for mechanical ventilation or any cardiorespiratory event requiring anaesthesiologist assistance. (NCT01428882)
Timeframe: Up to two hours, including colonoscopy performance and recovery period

,
Interventionparticipants (Number)
Transient oxygen desaturationBradycardiaArterial Hypotension
Midazolam Balanced Propofol Sedation523
Single-agent Propofol Sedation512

Percentage of Participants in the Control Group With an Oxygen Saturation Less Than 90 % Who Responded to Rescue NIPPV

We used non-invasive positive pressure ventilation (NIPPV) as a first rescue maneuver in control patients who developed an oxygen desaturation less than 90 % and reported on the percentage of participants who responded. The rescue was considered successful with recovery of oxygen saturation more than 90 % within 3 minutes. (NCT03529461)
Timeframe: 3 minutes following a desaturation event < 90 %

InterventionParticipants (Count of Participants)
Control Participants With Oxygen Desaturation < 90%8

Percentage of Participants With an Oxygen Desaturation Event < 90%

Percentage of participants who develop a peripheral oxygen saturation event < 90%. (NCT03529461)
Timeframe: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).

Interventionpercentage of participants (Number)
Control28.6
Experimental3.5

Percentage of Participants With an Oxygen Desaturation Event ≤ 94%

Percentage of participants who develop a peripheral oxygen saturation measured by pulse oximetry ≤ 94% (NCT03529461)
Timeframe: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).

Interventionpercentage of participants (Number)
Control57.1
Experimental14.3

Trials

3 trials available for propofol and Digestive System Disorders

ArticleYear
Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:7

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthetics, Intravenous; C

2009
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En

2010
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En

2010
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En

2010
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En

2010
Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Cholangiopancreatography, Endoscopic Retro

2011

Other Studies

7 other studies available for propofol and Digestive System Disorders

ArticleYear
[Effects of amino acid infusion in preventing intraoperative hypothermia: comparison between sevoflurane versus propofol].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:6

    Topics: Aged; Aged, 80 and over; Amino Acids; Anesthesia, Epidural; Anesthesia, General; Body Temperature; D

2014
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive

2008
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive

2008
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive

2008
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive

2008
Key opinion leader interview. Fospropofol disodium: new perspectives on endoscopic procedures.
    Reviews in gastroenterological disorders, 2008,Summer, Volume: 8, Issue:3

    Topics: Conscious Sedation; Digestive System Diseases; Endoscopy, Gastrointestinal; Humans; Injections, Intr

2008
Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures.
    Gastrointestinal endoscopy, 2011, Volume: 74, Issue:6

    Topics: Aged; Anesthetics, Intravenous; Body Mass Index; Conscious Sedation; Digestive System Diseases; Endo

2011
Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy.
    Endoscopy, 2003, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anesthesia, Intravenous; Anesthesiology

2003
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
    Gastrointestinal endoscopy, 2004, Volume: 60, Issue:3

    Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal

2004
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
    Gastrointestinal endoscopy, 2004, Volume: 60, Issue:3

    Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal

2004
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
    Gastrointestinal endoscopy, 2004, Volume: 60, Issue:3

    Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal

2004
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
    Gastrointestinal endoscopy, 2004, Volume: 60, Issue:3

    Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal

2004
Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series.
    Gastrointestinal endoscopy, 2000, Volume: 52, Issue:2

    Topics: Adult; Aged; Arousal; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Conscio

2000